Brii Biosciences
https://www.briibio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Brii Biosciences
China's 'Two Sessions': Vaccines, Drugs Seen Key To Easing Restrictions Amid New Spike
The latest policies from Beijing show that the Chinese government is readying its own new vaccines and drugs for COVID-19 in a bid to gradually ease some of the strictest pandemic restrictions globally, but progress is mixed and domestic reported infections are surging to their highest level since March 2020.
How Paxlovid Approval May Influence China's Pandemic Policies
In a surprise move, China has conditionally approved Pfizer’s oral COVID-19 antiviral Paxlovid, a development that may have far-reaching consequences for the country's pandemic policies and domestic drug developers.
Olympics Foreshadow Beijing's Intention To Follow Own Policy Path?
The Beijing Winter Olympics highlight a changing China that is becoming more confident and confrontational in its policies, although a willingness to challenge international rules could potentially stall the further introductions of novel vaccines and treatments at a critical juncture of the pandemic.
Winter Olympics Test China's 'Zero COVID' Limits, Treatment Constraints
Amid China’s increasingly inward-looking and dual circulation economic policies, the Beijing Winter Olympics provide rare insight into policymakers’ handling of a global event.
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
- Other Names / Subsidiaries
-
- Brii Biosciences Limited